On Thursday, Deutsche Bank adjusted its outlook on Davide Campari-Milano Spa (CPR:IM) stock, reducing the price target to €10.40 from the previous €11.00, while continuing to endorse it with a Buy rating.
This revision follows the company's first-half results, which aligned with consensus expectations, and an acknowledgment of current market challenges.
Campari (LON:0ROY) reported a second-quarter organic sales growth of 6.9%, surpassing the consensus forecast of 5.6%. However, organic earnings before interest and taxes (EBIT) growth of 5.6% fell short of the anticipated 6.5%, with the EBIT margin being 50 basis points below expectations. The earnings per share (EPS) for the first half of the year were consistent with predictions.
Despite the alignment with expectations, the company's forecast for fiscal year 2024 suggests an aspiration to outperform the industry. This ambition is set against a backdrop of softer market dynamics, heightened price competition in key markets, and a volatile macroeconomic environment.
The company's ability to expand gross margins is anticipated to face temporary challenges due to adverse weather affecting high-margin aperitifs and delays in renewing agave supply contracts.
In a statement, management indicated that flat EBIT margins are projected for FY24. This outlook reflects the company's current position in a market that is experiencing increased pressures and highlights the factors influencing its performance and strategic direction.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.